With your heavy case load, you can't afford to waste time searching for answers. Cardiology, 3rd Edition, by Drs. Crawford, DiMarco, and Paulus, offers you just the practical, problem-based guidance you need to quickly overcome any clinical challenge. 8 color-coded sections cover the 8 major clinical syndromes of cardiovascular disease—each section a virtual "mini textbook" on its topic! 40 new chapters keep you up to date with the latest advances in the field, while more than 2,000 lavish, high-quality illustrations, color photographs, tables, and ECGs capture clinical manifestations as they present in practice. It’s current, actionable information that you can put to work immediately for your patients! Offers a problem-based approach that integrates basic science, diagnostic investigations, and therapeutic management in one place for each cardiovascular disease so you can quickly find all of the actionable knowledge you need without flipping from one section to another. Features introductory bulleted highlights in each chapter that present the most pertinent information at a glance. Presents abundant algorithms to expedite clinical decision making. Includes more than 2,000 lavish, high-quality illustrations, color photographs, tables, and ECGs that capture clinical manifestations as they present in practice, and promote readability and retention. Includes 40 new chapters including Inherited Arrhythmia Syndromes, Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in CHD, Management of the Cyanotic Patient with CHD, Special Problems for the Cardiology Consultant Dealing with Bariatric/Gastric Bypass — and many more — that equip you with all of the latest knowledge. Presents "Special Problem" sections—many new to this edition—that provide practical advice on problems that can be difficult to treat.
Covers all aspects of the structure, function, neurochemistry,transmitter identification and development of the enteric nervoussystem This book brings together extensive knowledge of the structureand cell physiology of the enteric nervous system and provides anup-to-date synthesis of the roles of the enteric nervous system inthe control of motility, secretion and blood supply in thegastrointestinal tract. It includes sections on the enteric nervous system in disease,genetic abnormalities that affect enteric nervous system function,and targets for therapy in the enteric nervous system. It alsoincludes many newly created explanatory diagrams and illustrationsof the organization of enteric nerve circuits. This new book is ideal for gastroenterologists (includingtrainees/fellows), clinical physiologists and educators. It isinvaluable for the many scientists in academia, research institutesand industry who have been drawn to work on the gastrointestinalinnervation because of its intrinsic interest, its economicimportance and its involvement in unsolved health problems. It alsoprovides a valuable resource for undergraduate and graduateteaching.
A complete guide to the role of high-density lipoproteins (HDL) in new and emerging therapies With high-density lipoproteins (HDL) playing an increasing role in cardiovascular disease prevention, there is a growing need for an in-depth look at HDL and its clinical value. This book summarizes the current state of knowledge in the field, providing for the first time a comprehensive, systematic, stylistically coherent, and up-to-date review of the composition, structure, heterogeneity, metabolism, epidemiology, genetics, and function of HDL. Divided into three main parts, High-Density Lipoproteins first examines normal HDL particles, then describes defective HDL, and finally addresses the therapeutic normalization of subnormal levels and defective biological activities of this lipoprotein class. The book highlights the functional properties of HDL, which are relevant to the pathophysiology of atherosclerosis and thrombosis, and discusses the compositional and metabolic heterogeneity of HDL particles. Readers will come away with a clear understanding of the role of HDL in biological processes, the potential value of functional HDL as a therapeutic target, and how current and emerging therapies are poised to influence the treatment of heart disease in the future.
Offers a five-point approach to achieving total heart health, which includes relieving stress, reducing blood sugar, and battling fat and triglycerides.
The most comprehensive and current resource on the heart! This unparalleled text continues to focus on patient care rather than the scientific aspect of the specialty.
An expert's view on solving the challenges confronting today's pharmaceutical industry Author John LaMattina, a thirty-year veteran of the pharmaceutical industry and former president of Pfizer's Global R&D Division, is internationally recognized as an expert on the pharmaceutical industry. His first book, Drug Truths: Dispelling the Myths About Pharma R&D, was critically acclaimed for clearing up misconceptions about the pharmaceutical industry and providing an honest account of the contributions of pharmaceutical research and development to human health and well-being. As he toured the country discussing Drug Truths, Dr. LaMattina regularly came across people who were filled with anger, accusing the pharmaceutical industry of making up diseases, hiding dangerous side effects, and more. This book was written in response to that experience, critically examining public perceptions and industry realities. Starting with "4 Secrets that Drug Companies Don't Want You to Know," Devalued and Distrusted provides a fact-based account of how the pharmaceutical industry works and the challenges it faces. It addresses such critical issues as: Why pharmaceutical R&D productivity has declined Where pharmaceutical companies need to invest their resources What can be done to solve core health challenges, including cancer, diabetes, and neurodegenerative diseases How the pharmaceutical industry can regain public trust and resuscitate its image Our understanding of human health and disease grows daily; however, converting science into medicine is increasingly challenging. Reading Devalued and Distrusted, you'll not only gain a greater appreciation of those challenges, but also the role that the pharmaceutical industry currently plays and can play in solving those challenges. Get to know the author: Read an interview with John LaMattina or watch a video on ChemistryViews! Interview: John LaMattina: 30 Years in Pharma Video: Can the Pharmaceutical Industry Restory its Broken Image?
After half a century of doubt and debate, dyslipidemia has at last been accepted by cardiologists and the medical community at large as a major, treatable cause of atherosclerotic cardiovascular disease. A number of guidelines have been issued on the management of dyslipidemia in preventing coronary heart disease. A working knowledge of the various types of dyslipidemia and their treatment is highly relevant to modern medicine, with its accent on prevention. This book, written by a general practitioner, an epidemiologist, and a lipidologist, provides a broad and up-to-date perspective of dyslipidemia and is chiefly intended for use in primary care. It details normal lipid metabolism, describes the genetic and acquired causes of dyslipidemia and reviews the evidence that the latter is a risk factor for vascular disease. Most of the book, however, is devoted to the practicalities of screening, risk assessment and management of dyslipidemia in everyday clinical practice, including chapters summarizing current guidelines, the importance of diet and the role of lipid-lowering drugs. Cardiologists, general practitioners and pharmacists will find this volume indispensable.
This volume contains the papers, updated in some cases, presented at the first AISMC (Artificial Intelligence and Symbolic Mathematical Computations)conference, held in Karlsruhe, August 3-6, 1992. This was the first conference to be devoted to such a topic after a long period when SMC made no appearance in AI conferences, though it used to be welcome in the early days of AI. Some conferences were held recently on mathematics and AI, but none was directly comparable in scope to this conference. Because of the novelty of the domain, authors were given longer allocations of time than usual in which to present their work. As a result, extended and fruitful discussions followed each paper. The introductory chapter in this book, which was not presented during the conference, reflects in many ways the flavor of these discussions and aims to set out the framework for future activities in this domain of research. In addition to the introduction, the volume contains 20 papers.
A distinguished team offer views on various controversies surrounding lipids and lipoproteins, including the management of special patient groups and the benefits of lipid lowering in the secondary prevention of heart disease
PET and SPECT are two of today’s most important medical-imaging methods, providing images that reveal subtle information about physiological processes in humans and animals. Emission Tomography: The Fundamentals of PET and SPECT explains the physics and engineering principles of these important functional-imaging methods. The technology of emission tomography is covered in detail, including historical origins, scientific and mathematical foundations, imaging systems and their components, image reconstruction and analysis, simulation techniques, and clinical and laboratory applications. The book describes the state of the art of emission tomography, including all facets of conventional SPECT and PET, as well as contemporary topics such as iterative image reconstruction, small-animal imaging, and PET/CT systems. This book is intended as a textbook and reference resource for graduate students, researchers, medical physicists, biomedical engineers, and professional engineers and physicists in the medical-imaging industry. Thorough tutorials of fundamental and advanced topics are presented by dozens of the leading researchers in PET and SPECT. SPECT has long been a mainstay of clinical imaging, and PET is now one of the world’s fastest growing medical imaging techniques, owing to its dramatic contributions to cancer imaging and other applications. Emission Tomography: The Fundamentals of PET and SPECT is an essential resource for understanding the technology of SPECT and PET, the most widely used forms of molecular imaging. *Contains thorough tutorial treatments, coupled with coverage of advanced topics *Three of the four holders of the prestigious Institute of Electrical and Electronics Engineers Medical Imaging Scientist Award are chapter contributors *Include color artwork
This work looks at the issues of student learning and support, in the context of their own institution. Issues covered include student representation, underachievement and the overall aims and ethics of further and higher education.
Sets forth the state of the science and technology in plasma protein production With contributions from an international team of eighty leading experts and pioneers in the field, Production of Plasma Proteins for Therapeutic Use presents a comprehensive overview of the current state of knowledge about the function, use, and production of blood plasma proteins. In addition to details of the operational requirements for the production of plasma derivatives, the book describes the biology, development, research, manufacture, and clinical indications of essentially all plasma proteins with established clinical use or therapeutic potential. Production of Plasma Proteins for Therapeutic Use covers the key aspects of the plasma fractionation industry in five sections: Section 1: Introduction to Plasma Fractionation initially describes the history of transfusion and then covers the emergence of plasma collection and fractionation from its earliest days to the present time, with the commercial and not-for-profit sectors developing into a multi-billion dollar industry. Section 2: Plasma Proteins for Therapeutic Use contains 24 chapters dedicated to specific plasma proteins, including coagulation factors, albumin, immunoglobulin, and a comprehensive range of other plasma-derived proteins with therapeutic indications. Each chapter discusses the physiology, biochemistry, mechanism of action, and manufacture of each plasma protein including viral safety issues and clinical uses. Section 3: Pathogen Safety of Plasma Products examines issues and procedures for enhancing viral safety and reducing the risk of transmissible spongiform encephalopathy transmission. Section 4: The Pharmaceutical Environment Applied to Plasma Fractionation details the requirements and activities associated with plasma collection, quality assurance, compliance with regulatory requirements, provision of medical affairs support, and the manufacture of plasma products. Section 5: The Market for Plasma Products and the Economics of Fractionation reviews the commercial environment and economics of the plasma fractionation industry including future trends, highlighting regions such as Asia, which have the potential to exert a major influence on the plasma fractionation industry in the twenty-first century.
The definitive manual for treating the full range of heart problems. Summarizing the clinical portions of Hurst's THE HEART, 11/e, this point-of-care tool presents key points of pathophysiology, diagnosis, and treatment in a succinct, outline format. This new edition has been reorganized for a new consistent format and includes ACC/AHA treatment guidelines integrated throughout as well as quick-reference tables and algorithms.
Everything pharmacists need to know about drug information management Drug Information: A Guide for Pharmacists, Fourth Edition teaches students and professionals how to research, interpret, evaluate, collate, and disseminate drug information in the most effective and efficient manner possible. Updated throughout, the book also addresses other important issues such as the legal and ethical considerations of providing information, how to respond to requests for information, and how to determine what information should be made available. Drug Information: A Guide for Pharmacists, Fourth Edition covers essential topics such as: Formulating effective responses and recommendations for information Evaluation of drug literature The application of statistical analysis in the biomedical sciences Drug evaluation monographs Adverse drug reactions Medication and patient safety Investigational drugs New to this edition: Five new chapters: “Policy Development, Project Design, and Implementation,” “Drug Information in Ambulatory Care,” “Drug Information and Contemporary Community Pharmacy Practice,” “Drug Information Education and Training,” and “Pharmaceutical Industry and Regulatory Affairs: Opportunities for Drug Information Specialists” Key Concepts have been added to the beginning of each chapter and are identified with icons in the chapter text Case Studies and multiple-choice questions have been added to most chapters Twenty-two appendices include: Drug Consultation Request Form, Performing a PubMed® Search, Questions for Assessing Clinical Trials, and Questions to Consider for Critique of Primary Literature.
Data Mining and Warehousing' provides a complete assembly of the research available in this emerging and increasingly important field of research. The text offers tools, designs and outcomes of the utilisation of data mining and warehouseing technologies.
The classic guide to information management for pharmacists--updated to reflect the realities of today's practice The goal of Drug Information: A Guide for Pharmacists is to teach students and practitioners how to effectively research, interpret, evaluate, collate, and disseminate drug information in the most efficient and effective manner possible. Updated throughout, the book also addresses important issues such as the legal and ethical considerations of providing drug information. The Fifth Edition includes a timely new chapter on assessing drug promotions by pharmaceutical representatives and the need for counter-detailing. There is also a new chapter that bridges the gap between pharmacy informatics and drug information. COVERAGE INCLUDES: Formulating effective responses and recommendations for drug information Evaluation of the drug literature The application of statistical analysis in the biomedical sciences Drug evaluation monographs Adverse drug reactions Medication and patient safety Investigational drugs
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.